To: | Celgene Corporation (cmiller@cozen.com) |
Subject: | U.S. Trademark Application Serial No. 88202247 - ABECMA - CELG-1846US/ |
Sent: | September 16, 2019 06:05:31 PM |
Sent As: | ecom124@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88202247
Mark: ABECMA
|
|
Correspondence Address: |
|
Applicant: Celgene Corporation
|
|
Reference/Docket No. CELG-1846US/
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 16, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Attorney Camille Miller on September 16, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The following statement is added to the record:
Under the law of applicant’s country of origin, the foreign application or registration includes a standard character claim or the legal equivalent. In addition, the mark in the U.S. application consists of standard characters without claim to any particular font, style, size, or color.
See 37 C.F.R. §§2.51(c), 2.52(a); TMEP §§807.03(f), 1011.01.
/Alexandra El-Bayeh/
Trademark Examining Attorney
Law Office 124
(571) 270-5911
alexandra.el-bayeh@uspto.gov